CellCyte Genetics said it will "defend itself vigorously" against three shareholder lawsuits filed this week, and announced it has hired Philadelphia-based law firm Duane Morris.

The suits allege executives and outside shareholders of the small biotechnology company artificially inflated its stock price and defrauded investors by making misleading claims.